Serum vascular endothelial growth factor receptor-3 levels in patients with esophageal squamous cell cancer
Main Article Content
Abstract
AIM: Esophageal cancer is one of the most aggressive tumors of the gastrointestinal tract. In this study, we quantified the serum vascular endothelial growth factor-3 (VEGFR-3) expression in patients with esophageal squamous cell carcinoma (ESCC) to evaluate the role of VEGFR-3 in ESCC.
MATERIALS AND METHODS: Ninety five patients with ESCC were studied. Pre-therapy and preoperative samples were stored and ELISA was used to designate the concentrations of VEGFR-3.
RESULTS: The serum values of VEGFR-3 were significantly higher in patients with ESCC than in healthy donors (p<0.0001).
CONCLUSIONS: The results imply a very good sensitivity of VEGFR-3 in ESCC. VEGFR-3 may be a good diagnostic biomarker for ESCC.
Article Details
How to Cite
Sümer, Aziz, et al. “Serum Vascular Endothelial Growth Factor Receptor-3 Levels in Patients With Esophageal Squamous Cell Cancer”. Annali Italiani Di Chirurgia, vol. 88, no. 1, Jan. 2017, pp. 20-25, https://annaliitalianidichirurgia.it/index.php/aic/article/view/114.
Issue
Section
Article